Form 4 holding
10%+ Owner
Corvus Pharmaceuticals, Inc.
- Security class
- Common Stock, $0.0001 par value
- Shares / value
- 3,275,616
- Estimated value
- $2,587,737
- Report date
- 11 Aug 2022
- Price
- $0.7900
- Ownership
- By Funds
ADAMS STREET PARTNERS LLC - 10%+ Owner at Corvus Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- CRVS on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by ADAMS STREET PARTNERS LLC since 13 Sep 2025
Reported holdings for ADAMS STREET PARTNERS LLC in Corvus Pharmaceuticals, Inc.
Form 4 holding
10%+ Owner
Corvus Pharmaceuticals, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 15,000
- Estimated value
- Report date
- 11 Aug 2022
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for ADAMS STREET PARTNERS LLC in Corvus Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.